Are you exhausted at work? Do you experience chronic stress and fatigue that impairs your ability to be as great as you can be? These are all symptoms of burnout, and you are not alone. As a leader, it is critical to be aware of burnout and its consequences. It is also critical that you manage your personal health. Learn more about how to avoid and minimize burnout during this session.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to use mitigation strategies to manage and minimize burnout potential.
Being a member of a marginalized group affects workplace experiences, including engagement. Marginalized groups often face overt and subtle discrimination and higher mental and emotional taxation, both in and outside of work. An inclusive, employee-centered culture is an investment that will pay off in many ways, but it requires time, resources, and a collaborative and synchronized effort to establish. This session focuses on how a culture of inclusion can, and will, develop when organizational leadership works at its best.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss how to promote a culture of inclusion within their nursing unit.
Developing a cohesive and effective team is one of the most challenging, and sometimes time consuming, tasks a leader will encounter. This task is more complicated when it has to be accomplished virtually and teams are not in the same room. This session uncovers some of these challenges and provides tips for fostering teamwork and collaboration.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe ways to virtually lead teams.
Because patients with chronic kidney disease (CKD) have an increased risk of death from cardiovascular disease, recognizing the pathologic processes of cardiomyopathy and complications that can result in uremic cardiomyopathy is key for nephrology nurses. This session addresses the epidemiology, pathophysiology, diagnosis, and treatment recommendations (including types of dialysis) for cardiomyopathy in patients with CKD. The relationship of uremic cardiomyopathy to mineral and bone disorders seen in CKD is also discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to care for patients with CKD who are developing uremic cardiomyopathy with early recognition of this complication.
This session features a patient’s journey from in-center hemodialysis to home hemodialysis, including adjustments to the dialysis prescription to enable the patient to feel healthy and energized rather than drained and exhausted. Steps throughout the journey, such as self-cannulation, are shared so the nephrology nurse can appreciate the perspective from the other side of the bed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the patient perspective of the CKD journey and patient advocacy techniques.
This session focuses on assessments to use and findings that point to a patient developing hypotension during and after dialysis. A highlight is discussion of the evidence-based treatment for hypotension in dialysis patients.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to provide care to patients who are hypotensive in the post-dialytic period.
This session addresses the management of complex hypertension. Etiology, evaluations, treatment, and desired outcomes are the focus as we explore this complex and challenging complication. Case study presentations are used to demonstrate patient care.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to care for patients with complex hypertension using evidence-based treatment.
This session focuses on the challenge of caring for a patient with chronic kidney disease (CKD) who experiences hypertension resistant to treatment. Causes, assessment, and management from medical and nursing perspectives are addressed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Raymond Townsend, MD – Consultant for Medtronic’s Renal Denervation for Hypertension studies; Contributor to UpToDate’s resistant hypertension topic
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe evidence-based treatment for patients with resistant hypertension.
The use of extended work shifts and overtime has escalated as hospitals cope with a shortage of registered nurses. The prevalence of extended work periods can impact patient safety. This session focuses on the need to address safe work hours in the workplace and describes ways to address workplace bullying and violence.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to use evidence-based practice when planning for and maintaining safe work environments.
Assessing and intervening for electrolyte disturbances is complex and confusing at times. This presentation is an overview of what we can see, and what our patients will be experiencing, when those imbalances present. We compare the basic IV types and when they are used as interventions.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will have an increased confidence and ability to care for kidney patients with fluid and electrolyte imbalances that must be addressed.
Patients have varying degrees of kidney disease and therefore need varying medication dosage adjustments. This presentation discusses how to distinguish renal dosing adjustments for antihypertensives, diabetic medications, and antimicrobials among others. A highlight for nephrology APs are reminders for effective renal drug dosing.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will have increased knowledge and ability to provide safe medication dosages to patients in varying stages of CKD.
Leaders at all levels are responsible for fostering teamwork and reaching “across the aisle” to promote inclusion and unity. We, as nurses, need to consider our roles in fostering a culture that is diverse and inclusive of other people, other ideas, and other ways of doing things. This session provides insights and strategies that we can all use to build our own leadership practices.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
Sponsored by AstraZeneca
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to promote inclusion, equity, and accountability to enable systems change in both formal and informal leadership positions.
Patients with chronic kidney disease are more likely to be prescribed opioids for pain associated with chronic conditions and comorbidities such as diabetes and hypertension. This session reviews the recommendations in the CDC Guideline for Prescribing Opioids for Chronic Pain, which will assist nephrology nurses to provide safer and more effective chronic pain treatment options, improve opioid prescribing practices, and reduce the number of patients with opioid use disorder, opioid misuse, or opioid-related harm.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to utilize the CDC Guideline for Prescribing Opioids for Chronic Pain appropriately.
Urgent start PD is being used increasingly for individuals in need of acute dialysis. This session provides an overview of urgent start PD, including when it should be introduced, for which patients, nursing implications, patient care requirements, and the pathophysiologic changes associated with this treatment modality. The takeaway is an understanding of the differences among urgent start, early start, and traditional start PD.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Lucy B. Todd, MSN, ACNP-BC, CNN – Employed by Baxter Healthcare
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe the differences between urgent PD, urgent start, and traditional PD, along with indications and nursing implications for each treatment.
A how-to guide on acquiring organizational skills and tips to improve workflow when managing PD patients. Learn how to effectively manage your time, build a nurse toolkit of resources, and strategically navigate through unexpected events that may occur during the day.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/2/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
Nephrology nurses frequently care for patients with CKD who have side effects from hyperkalemia. This session discusses the challenges and a nephrology nurse’s role in planning care for these patients, including pharmacologic and non-pharmacologic measures.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
Supported through an educational grant from Vifor Pharma.
No other commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will state an increased ability to plan care for patients with CKD experiencing hyperkalemia.
What are nurse residency programs and why are they becoming increasingly important in today’s work environment? This session answers these questions and provides an overview of nurse residency programs, including benefits to specialty areas, costs, suggestions for marketing, and the necessary program evaluation process.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will describe an increased knowledge of, and support for, new nurse residency programs.
Liver disease is often noted in patients with chronic kidney disease (CKD). This session reviews risk factors and the development of liver failure in patients with CKD, as well as diagnostic evaluation and therapeutic management in outpatient and inpatient settings. The discussion also focuses on the challenges of managing advanced liver failure and advanced CKD.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the plan of care for patients with CKD who also have liver disease.
This presentation provides you with a fundamental overview of the peritoneal membrane anatomy and physiology. Additionally, a review of the peritoneal transport process, PD solutions, membrane transport variability, and how they relate to the PET are discussed.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/2/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
During the pandemic, telehealth took a more prominent role in how people interacted with their healthcare providers. This session discusses ways to incorporate telehealth into your clinic using best practices and lessons learned from other facilities that have implemented telehealth. Tips on reimbursement and billing, as well as predictions about the future of telehealth are shared.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Michael A. Kraus, MD – Salary from Fresenius Kidney Care, Inc.
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to incorporate telehealth best practices into daily workflow.
Have you worked with a patient who stated, “My neighbor said I should take these supplements because they will make me better.” What was your response? This session addresses this scenario and provides tips for how nurses can handle conversations with patients about herbals and supplements and their potential impact on kidney health.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Kristin Larson, MSN, RN, AGNP-BC – Salary from United Health Group and Speaker’s Bureau for AstraZeneca
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will state an increased competence with their ability to talk with patients about herbals and supplements and the potential interaction with prescribed medications.
Patient activation – the willingness and ability of a person to manage their healthcare – provides nephrology nurses with a concept and measurement tool to classify people with kidney disease into various activation levels. Applying an individualized approach to patients based on their activation level may increase patients’ self-care and self-management of their disease process.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Paul Bennett, PhD, MHSM, RN, BN, GCertSc – Salary from Satellite Healthcare
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to utilize a patient activation system (when appropriate) to determine appropriate interventions and management.
This two-part presentation assists the PD nurse in training a new PD patient and serves as an introduction to PD catheters. This course is based on the ISPD Syllabus for Teaching Peritoneal Dialysis to Patients and Caregivers with an overview of the training plan and helpful resources that reinforce some of the learning called out in the syllabus. Create an effective training experience for your new PD patient as you gain essential skills to transfer knowledge to adult learners in a way that is educational, interesting, and interactive.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/2/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
Nephrology nurses care for patients with CKD who complain of severe pruritus that is decreasing their perceived quality of life. This session discusses a nephrology nurse’s role in planning care to improve quality of life for these patients.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
Supported through an educational grant from Cara Therapeutics and Vifor Pharma.
No other commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will state an increased ability to plan care for patients with CKD experiencing severe pruritus.
Innovative ways to increase both deceased and living organ donation are being explored. Many programs now transplant kidneys from deceased donors who had hepatitis C. Donors with HIV can now donate kidneys to recipients with HIV (HOPE Act). The Executive Order on Advancing American Kidney Health also has tremendous potential for increasing kidney donation and transplantation. This session reviews ground-breaking paradigms in transplantation.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe innovative methods to increase kidney transplantation.
Medications to manage HIV may impact renal function. This session reviews the current state of HIV progression and survivability, first-line drugs used to treat HIV, and the potential impact of these medications on renal function, such as kidney injury and HIV-associated nephropathy (HIVAN).
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to successfully plan care for patients with CKD and HIV based on the knowledge of the relationship between HIV and kidney function.
Gain insight into another member of the patient care team as a physician shares his perception of his role in patient care and dialysis. This session highlights the patient’s perspective of their disease and how these two views of kidney disease and dialysis are similar and dissimilar.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Kamyar Kalantar-Zadeh, MD, MPH, Phd – Salary from University of California Irvine and Fresenius, DaVita
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe the perspectives of other health care providers about incremental dialysis.
In part two of this presentation, optimize your patient’s success at home by using approaches and available resources that engage in the continuity of care between the patient and the care team beyond the clinic setting.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/3/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
Nephrology nurses often care for patients with comorbid diseases but may not be as versed in caring for patients with severe mental illness (SMI). This session provides information about symptoms of SMI and research findings on mental health issues and kidney disease. A highlight of this session is the importance of this information to daily practice and how to provide the most effective care to patients with SMI.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe possible links between mental illness and CKD.
Hyper- and hypotension are a concern for nephrology nurses caring for patients with chronic kidney disease (CKD) receiving dialysis. This session reviews the pathophysiology of hypertension in CKD, compares current hypertension guidelines (KDIGO, ACC/AHA), and addresses the implications of the SPRINT trial on future hypertension guidelines.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to explain the latest guidelines to provide evidence-based care to patients with hypertension.
The goal of fluid management in PD is the normalization of extracellular volume. Learn to apply a structured diagnostic approach to the evaluation of fluid balance problems through a review of fundamental concepts in achieving target weight in PD.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/3/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
This session includes abstract presentations with a clinical or case study focus.
- Obtaining Hemoglobin S and Hematocrit Levels Post Red Blood Cell Exchange: Target and Actual Result by Kyle Gault, BSN, RN, CNN, CDN, QIA (ASCP)
- The Effect of Educational Intervention (EFEKT) to Improve Blood Pressure Control Among Minority Patients with Chronic Kidney Disease by Anitha Philip, APRN, FNP-C
- Infection Prevention through Collaboration in Hemodialysis Line Care by Nicole Ingram, BSN, RN, CNN
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to interpret studies that address various issues with care of patients with CKD and related conditions.
This session includes abstract presentations with a research focus.
- Validity of Self-Report and Objective Fatigue Measures in Hemodialysis by Bincy Joshwa, PhD, MSN, RN
- Kidney Transplant Recipients' Perceptions of Consumer-Based Mobile Health Applications for Self-Health Tracking by Tara O’Brien, PhD, RN, CNE
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe research conducted related to various issues in nephrology care.
The goal of fluid management in PD is the normalization of extracellular volume. Learn to apply a structured diagnostic approach to the evaluation of fluid balance problems through a review of fundamental concepts in achieving target weight in PD.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/3/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
The Executive Order on Advancing American Kidney Health set a goal of having 80% of individuals with end-stage kidney disease (ESKD) receive home hemodialysis or a pre-emptive transplant. The future of home dialysis will be transformed, but what that future will look like is still to be determined. This session addresses these issues, reflecting on experiences from the 1970s to now and exploring potential future trends.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to recount the history of home dialysis and the current and future implications related to the historical perspectives.
Learn more about the incidence and presentations of COVID-19 in the pediatric population, as well as changes in pediatric nephrology practice as a result of COVID. The effects of COVID on pediatric transplant protocol is a highlight of this session.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the plan of care for pediatric nephrology and transplant patients with COVID-19 based on current evidence.
The pathophysiology of renal cell carcinoma and diagnostic tools open this session. Grading, the respective treatment based on the grading of cancer, and potential for transplantation in patients with renal cell carcinoma are addressed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to utilize evidence-based care for patients with renal cell carcinoma.
An overview of important concepts regarding prescription management and PD adequacy is presented first; then the presentation moves on to the application of these principles in a workshop-style format.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/4/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
Changes in the management of chronic kidney disease (CKD) occur frequently, and treatments previously used sometimes re-emerge. Conservative management of CKD is being viewed as something new while it has been used before. This session examines the current state of modality use for CKD and compares it to conservative management. How to individualize plans of care to provide the best care for each individual is discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to utilize evidence-based care for patients being treated with conservative management for kidney failure.
An overview of important concepts regarding prescription management and PD adequacy is presented first; then the presentation moves on to the application of these principles in a workshop-style format.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/4/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
Poster presenters discuss their clinical projects and research findings.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to assess innovations being used by other professionals in the specialty and evaluate the potential of implementing the improvements into practice.
Nephrology Nursing Journal Editor-in-Chief Beth Ulrich reviews the manuscript development, peer review, and publication processes and provides tips for developing a plan for writing and submitting a manuscript for publication.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to state an increased knowledge and confidence about the publication process and increased willingness to consider submitting manuscripts for publication.
Calciphylaxis is not uncommon in individuals with kidney disease. Review the incidence, prevalence, risk factors, and diagnostic criteria for calciphylaxis. Discussion covers skin lesions in calciphylaxis and emerging treatment options to halt the disease’s progression.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Sagar Nigwekar, MD – Consultant for Epizon Pharma, Inc., Fresenius Medical Care Renal Therapies Group, Laboratoris Sanifit, Guidepoint; Grant for research work from Hope Pharma, Laboratoris Sanifit
There are no other speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to plan care for patients with calciphylaxis based on the best evidence.
Nurses are in a unique role to help increase patients’ long-term success with PD by focusing on preventive strategies. Learn how to use the skills and knowledge of your nursing practice to facilitate positive patient outcomes with respect to preventing infectious complications.
Continuing Education Instructions and Disclosure Information:
Access to the evaluation links will be available until 6/4/2021.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CE evaluation. You will be able to print your CE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
All conflicts of interest have been resolved by an acceptable method. The facilitator will verbally disclose his/her affiliation with the commercial support organization prior to the onset of the activity and will identify off-label or investigational information.
Commercial Support and Sponsorship:
We gratefully acknowledge the support of Baxter Healthcare for providing funding for this activity.
Accreditation Statement:
This activity is approved for 1 hour of continuing education credit to nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour.
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP in collaboration with FibroGen.
Apply for credit here: http://peerview.com/ANNA21-survey
Activity Description
Anemia is a common complication of chronic kidney disease (CKD), which increasingly affects aging populations and patients who have advanced CKD. It is associated with increased cardiovascular risk, hospitalization, and mortality. Erythropoiesis-stimulating agents, either alone or in combination with iron supplementation, are the current standard of treatment; however, these agents have limitations. Hypoxia-inducible factor (HIF) stabilization via prolyl hydroxylase (PH) domain inhibition is a promising new approach to treat anemia in CKD. Several HIF-PH inhibitors are in development, and the available clinical trial data suggest that these inhibitors offer a number of advantages over the current standard of care. In this live, case-based web broadcast, experts on anemia management in CKD will highlight the latest evidence for HIF-PH inhibitors and provide guidance on integrating these advances into clinical practice.
Target Audience
This activity has been designed to meet the educational needs of nephrology nurses, nephrologists, and other clinicians involved in the management of anemia in patients with CKD.
Educational Objectives
Upon completion of this activity, participants will be able to:
- Review the prevalence, burden, and pathophysiology associated with anemia among patients with CKD
- Identify the benefits and limitations of current therapeutic strategies to manage anemia associated with CKD
- Assess the safety and efficacy data of HIF-PH inhibitors in patients with anemia in dialysis-dependent (DD)-CKD or nondialysis-dependent (NDD)-CKD
- Personalize treatment of anemia in patients with CKD in accordance with current evidence, expert recommendations, and individual patient needs
Providership, Credit, and Support
Physician Continuing Medical Education
Medical Learning Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Medical Learning Institute, Inc. designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is developed with our educational partner, PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP in collaboration with FibroGen.
Nursing Continuing Professional Development
Medical Learning Institute, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Successful completion of this nursing continuing professional development activity will be awarded 1.25 contact hour(s) and 0.5 contact hour(s) in the area of pharmacology.
Faculty
Chair & Presenter
Rajiv Agarwal, MD, MS
Indiana University School of Medicine
Indianapolis, Indiana
Presenters
Steven Fishbane, MD
Northwell Health
Great Neck, New York
Shushanne Wynter-Minott, DNP, FNP-BC, APRN
Davita Integrated Kidney Care
Florida Atlantic University
Boca Raton, Florida
Disclosure and Conflict of Interest Policy
The Medical Learning Institute, Inc. (MLI) requires faculty, planners, staff, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they, and their spouse/life partners, may have as related to the content of this activity. These disclosures will be provided to learners prior to the start of the activity. All identified COI are thoroughly vetted and resolved according to MLI policy. MLI is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this accredited activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire activity. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you upon completion. You will receive your certificate from email@email.peerviewpress.com. If you have questions regarding the receipt of your emailed certificate, please contact via email at info@PeerView.com.
For nurses, the post-test and evaluation are required in their entirety and a score of 70% or higher is needed to obtain Nursing Continuing Professional Development (NCPD) contact hours.
About This CME Activity
PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.
This session provides an update on health policy impacting nephrology nursing. Expert speakers share legislative and regulatory policies that have actual or potential power to influence nursing practice, education, and the delivery of care to patients with kidney disease.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to participate in health policy activities in their community.